Invest II Scsp Droia

Insider Reports History

Location
Luxembourg, Luxembourg
Signature
Droia Invest II SCSp, By: DF II GP Sarl, By: /s/ Janwillem Naesens, Name: Wepaven BV (represented by Janwillem Naesens), Title: Manager
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Invest II Scsp Droia:

Company Role Class Num Shares Value Price $ Report Date Ownership
Cyteir Therapeutics, Inc. 10%+ Owner Common Stock 3,536,803 $5,977,197 $1.69 22 Jun 2021 Direct
Cyteir Therapeutics, Inc. 10%+ Owner Series B Convertible Preferred Stock 0 22 Jun 2021 Direct
Cyteir Therapeutics, Inc. 10%+ Owner Series C Convertible Preferred Stock 0 22 Jun 2021 Direct

Insider Reports Filed by Invest II Scsp Droia

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000089924321025828-droia-invest-ii-scsp-2021-06-22 Cyteir Therapeutics, Inc. 22 Jun 2021 4 +$4,999,986 4 10%+ Owner 24 Jun 2021, 20:55
/report/000089924321024599-droia-invest-ii-scsp-2021-06-17 Cyteir Therapeutics, Inc. 17 Jun 2021 0 $0 3 10%+ Owner 17 Jun 2021, 21:44